IL103730A0 - Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding - Google Patents
Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor bindingInfo
- Publication number
- IL103730A0 IL103730A0 IL103730A IL10373092A IL103730A0 IL 103730 A0 IL103730 A0 IL 103730A0 IL 103730 A IL103730 A IL 103730A IL 10373092 A IL10373092 A IL 10373092A IL 103730 A0 IL103730 A0 IL 103730A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic
- tissue
- expression
- specific
- receptor binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79085791A | 1991-11-12 | 1991-11-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103730A0 true IL103730A0 (en) | 1993-04-04 |
Family
ID=25151941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103730A IL103730A0 (en) | 1991-11-12 | 1992-11-12 | Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN1073264A (en) |
AU (1) | AU3130493A (en) |
IL (1) | IL103730A0 (en) |
PT (1) | PT101051A (en) |
WO (1) | WO1993009798A1 (en) |
ZA (1) | ZA928730B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2269075A1 (en) * | 1996-10-16 | 1998-04-23 | Regeneron Pharmaceuticals, Inc. | Method of enhancing the delivery of growth factors |
WO1998021245A1 (en) * | 1996-11-08 | 1998-05-22 | Roche Diagnostics Gmbh | Highly affine antibody against human bdnf, method for the production and use thereof |
EP1173768B1 (en) * | 1999-05-03 | 2006-10-25 | Evotec AG | Methods of diagnosing, prognosing, monitoring the progression or evaluating of a treatment of depression on basis of increased cerebrospinal fluid levels of neurotrophin 3 |
EP1050758A1 (en) * | 1999-05-03 | 2000-11-08 | Evotec BioSystems AG | Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3 |
US6548062B2 (en) | 2000-02-29 | 2003-04-15 | Cephalon, Inc. | Method of treating cancer with anti-neurotrophin agents |
CN110812532A (en) * | 2019-08-20 | 2020-02-21 | 中山大学 | Construction method of tissue engineering scaffold for repairing spinal cord injury by targeted promotion of corticospinal tract connection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868107A (en) * | 1986-11-18 | 1989-09-19 | The United States Of America As Represented By The Department Of Health And Human Services | Method for detecting antibodies against neuropeptides and drugs in human body fluid |
-
1992
- 1992-11-12 IL IL103730A patent/IL103730A0/en unknown
- 1992-11-12 PT PT101051A patent/PT101051A/en not_active Application Discontinuation
- 1992-11-12 ZA ZA928730A patent/ZA928730B/en unknown
- 1992-11-12 WO PCT/US1992/009652 patent/WO1993009798A1/en active Application Filing
- 1992-11-12 CN CN92114650A patent/CN1073264A/en active Pending
- 1992-11-12 AU AU31304/93A patent/AU3130493A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1073264A (en) | 1993-06-16 |
WO1993009798A1 (en) | 1993-05-27 |
PT101051A (en) | 1994-02-28 |
ZA928730B (en) | 1993-05-10 |
AU3130493A (en) | 1993-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL105930A0 (en) | Therapeutic respiration device | |
GB2219735B (en) | Reclining device | |
EP0875199A4 (en) | Organism state measuring device and relaxation instructing device | |
GB9500368D0 (en) | Medicine injection device | |
IL109094A0 (en) | Human tnf muteins | |
GB9320322D0 (en) | Coupling apparatus and seat structure | |
EP0708237A4 (en) | Fuel treatment device | |
EP0386246A4 (en) | Device for local heating and stereoresonator for local heating | |
IL101678A0 (en) | Membrane bound probes and their construction | |
IL106037A0 (en) | Therapeutic and diagnostic methods based on neurotrophin-4-expression | |
AU115939S (en) | Combined infusion device and charger unit | |
EP0538659A3 (en) | Extracorporal therapy device | |
EP0711830A3 (en) | Human and murine galanin receptor | |
GB2262698B (en) | Flea-rid and grooming apparatus and methods | |
GB9626446D0 (en) | Therapeutic device | |
IL103730A0 (en) | Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding | |
GB2255283B (en) | Medical device | |
EP0792282A4 (en) | Human endothelin-bombesin receptor | |
GB9002217D0 (en) | Back rehabilitation procedure and means | |
GB9120768D0 (en) | Diagnostic and prognastic materials and methods | |
ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use | |
EP0587806A4 (en) | Therapeutic and diagnostic methods based on neurotrophin-4 expression. | |
EP0803570A4 (en) | Mutant human insulin receptor dna | |
GB9107172D0 (en) | Therapeutic and diagnostic compounds | |
GB9101436D0 (en) | Diagnostic and therapeutic compounds |